US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

48.06

+0.57331.21%

Post-market: 47.11-0.9528-1.98%19:30 EDT

Volume:5K

Turnover:221.35K

Market Cap:132.51M

PE:- -

High:48.19

Open:48.00

Low:47.87

Close:47.49

52wk High:48.78

52wk Low:27.34

Shares:2.76M

Float Shares:2.76M

Volume Ratio:1.31

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64

Lilly-Backed Gene Therapy Study Tracks Long Term Safety in Vestibular Schwannoma

Press Release: Caredx to Report Second Quarter 2026 Financial Results on July 30, 2026

Guardant Health is Maintained at Buy by Guggenheim

Guardant Health price target raised to $190 from $160 at Guggenheim

Ernexa Therapeutics announces new ERNA-101 preclinical data

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)

Celcuity announces FDA approval of Revtorpyk

3 Service Sector Stocks With Pricing Power Investors Should Watch

Simply Wall St.

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

Guardant Health is Maintained at Buy by Canaccord Genuity

Guardant Health price target raised to $205 from $135 at Canaccord

BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s

Voyager Therapeutics advances tau-silencing gene therapy program

Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX)

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

Travere Therapeutics Grants Inducement Equity Awards for 41,600 Shares to Six New Employees

Spyre Therapeutics (SYRE) Faces Broad Russell Index Removal Is Benchmark Appeal Quietly Eroding?

Simply Wall St.

Travere Therapeutics CAO Sandra Calvin to Retire; Controller John Torell Set to Succeed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LFSC/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":48.0628,"timestamp":1787688000000,"preClose":47.4895,"halted":0,"volume":4612,"hourTrading":{"tag":"盘后","latestPrice":47.11,"preClose":48.0628,"latestTime":"19:30 EDT","volume":194,"amount":9205.2812,"timestamp":1787700602165,"change":-0.9528,"changeRate":-0.019824,"amplitude":0.019142},"delay":0,"changeRate":0.012072142263026633,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Closed","change":0.5733,"latestTime":"08-25 16:00:00 EDT","open":48,"high":48.19,"low":47.87,"amount":221346.80604,"amplitude":0.006738,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":47.4895,"sharesOutstanding":2657035,"nav":47.45,"aum":130821310.75,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":47.11,"preClose":48.0628,"latestTime":"19:30 EDT","volume":194,"amount":9205.2812,"timestamp":1787700602165,"change":-0.9528,"changeRate":-0.019824,"amplitude":0.019142},"volumeRatio":1.311494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.311494,"shares":2757035,"dividePrice":0,"high":48.19,"amplitude":0.006738,"preClose":47.4895,"low":47.87,"week52Low":27.3402,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":48.0628,"eps":0,"divideRate":0,"volume":4612,"delay":0,"ttmEps":0,"open":48,"prevYearClose":36.6147,"prevWeekClose":47.7953,"prevMonthClose":45.55,"prevQuarterClose":45.2033,"fiveDayClose":47.489,"twentyDayClose":45.3952,"sixtyDayClose":39.3901},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652278224","title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2652278224","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652278224?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:57","pubTimestamp":1784235433,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa disposes of 116 common shares worth $18,941.64Guardant Health director Tariq Musa cut his stake to 11,182 shares following a sale disclosed in a Form 4.Musa sold 11","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDLc18J55:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0109394709.USD","HELX","GH","BK4588","BK4535","GNOM","BK4551","LU0889565916.HKD","LU0320765992.SGD","LFSC","GDOC","EKG","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652425738","title":"Lilly-Backed Gene Therapy Study Tracks Long Term Safety in Vestibular Schwannoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2652425738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652425738?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:31","pubTimestamp":1784219512,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The long term follow up study of AAVAnc80-antiVEGF gene therapy a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lilly-backed-gene-therapy-study-tracks-long-term-safety-in-vestibular-schwannoma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lilly-backed-gene-therapy-study-tracks-long-term-safety-in-vestibular-schwannoma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","GNOM","IBB","IBBQ","FBT","BK4585","LFSC","BK4588","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651444182","title":"Press Release: Caredx to Report Second Quarter 2026 Financial Results on July 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651444182","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651444182?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:37","pubTimestamp":1784205420,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif.--(BUSINESS WIRE)--July 16, 2026--CareDx, Inc. (Nasdaq: CDNA) -- a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDNA","BK4585","BK4588","BK4139","LFSC","GNOM","SYNB","BMED","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651290441","title":"Guardant Health is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651290441","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651290441?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:10","pubTimestamp":1784203800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 16, 2026 08:10 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","BK4535","GDOC","LU0889565916.HKD","EKG","GH","PTH","LU0109394709.USD","GNOM","LU0320765992.SGD","BK4196","HELX","BK4588","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651344620","title":"Guardant Health price target raised to $190 from $160 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651344620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651344620?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199651,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Guardant Health (GH) to $190 from $160 and keeps a Buy rating on the shares. The firm says its Q2 web ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","BK4535","GDOC","BK4588","GH","LFSC","LU0109394709.USD","EKG","BK4585","BK4551","GNOM","PTH","BK4196","LU0889565916.HKD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651646874","title":"Ernexa Therapeutics announces new ERNA-101 preclinical data","url":"https://stock-news.laohu8.com/highlight/detail?id=2651646874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651646874?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:15","pubTimestamp":1784117721,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics (ERNA) announced new preclinical data independently validating the anti-tumor activity of its lead cell therapy candidate, ERNA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-announces-new-erna-101-preclinical-data-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-announces-new-erna-101-preclinical-data-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ERNA","SYNB","BK4585","FBT","BK4139","IBBQ","GNOM","BK4588","LFSC","CNCR","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651452589","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651452589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651452589?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:40","pubTimestamp":1784112028,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company (MRK), Annexon Biosciences (ANNX) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-annexon-biosciences-annx-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-annexon-biosciences-annx-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","BK4139","LU1934455194.USD","IE00BLSP4452.SGD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD","LU2089984988.USD","ANNX","LU0006306889.USD","SG9999001440.SGD","LU0130102774.USD","LU1093756325.SGD","HELX","LU1057294990.SGD","FHLC","LU0861579265.USD","LU2125909247.SGD","LU0965508806.USD","LU1116320737.USD","LU2361044865.SGD","SG9999014559.SGD","IE00BJT1NW94.SGD","LU2023250843.SGD","LU1974910355.USD","LU0942090050.USD","LU0965509010.AUD","LU2491050071.SGD","LU0266013472.USD","GNOM","LU0203347892.USD","LU0211331839.USD","LU0648001328.SGD","LU2360032135.SGD","LU0106261372.USD","LU1929549753.HKD","IE0002141913.USD","BK4516","LU0265550946.USD","LU1035773651.USD","BK4588","EKG","SG9999014567.USD","LU1941712264.USD","LU0477156953.USD","LU1585245621.USD","LU1061106388.HKD","BK4551","BK4533","GDOC","BK4550","PPH","IE00BJJMRZ35.SGD","LU0238689110.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1066053197.SGD","LU1989771016.USD","LU2468319806.SGD","LU1917777945.USD","LU1066051498.USD","LU1162221912.USD","LU0868494708.USD","SG9999013999.USD","LU1989772923.USD","LU2361044949.HKD","PAWZ","LU0859254822.USD","IE00B2B36J28.USD","BK4534","SG9999002232.USD","LU2106854487.HKD","LU1989772840.SGD","BK4585","BMED","LU2461242641.AUD","BK4196","IHE","LU0208291251.USD","LU0234572021.USD","LU0122379950.USD","LU2125909593.SGD","LU1201861249.SGD","IE0009355771.USD","LU1023059063.AUD","LU2361045086.USD","LU1934455277.USD","LU0098860793.USD","RXL","IE00BSNM7G36.USD","LU0320765646.SGD","SG9999014575.USD","LU2112291526.USD","LU1069347547.HKD","LU2491049909.HKD","LU0320765992.SGD","LU1571399168.USD","LU0289739699.SGD","IXJ","LU1941712348.USD","LU0965509283.SGD","LU0868494617.USD","LU0265550359.USD","LU0985320562.USD","JDOC","FTXH","LU1037948897.HKD","HRTS","LU1430594728.SGD","SG9999015341.SGD","LU0124676726.USD","BK4007","LU0058720904.USD","LU0070302665.USD","LU0130517989.USD","LU1923622614.USD","LU0965509101.SGD","LU2125154935.USD","SG9999015358.SGD","PTH","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","LU0109394709.USD","LU1291159041.SGD","LU2491050154.USD","SG9999001176.USD","LFSC","LU1934455863.HKD","LU0203345920.USD","LU2324357040.USD","LU2023250504.SGD","LU1699723380.USD","LU1983299246.USD","LU1116320901.HKD","IE00BBT3K403.USD","LU2433249047.HKD","LU2125154778.USD","BK4535","LU0689626769.HKD","SG9999001176.SGD","LU0320765489.SGD","VHT","LU1066051225.USD","BK4559","IYH","LU1066051811.HKD","LU2357627491.SGD","MRK","LU0889565916.HKD","GH","IE00BN8TJ469.HKD","SG9999014542.SGD","LU0432979614.USD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651655484","title":"Celcuity announces FDA approval of Revtorpyk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651655484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651655484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:55","pubTimestamp":1784062511,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) announced that the U.S. Food and Drug Administration approved REVTORPYK for the treatment of patients with hormone receptor positiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","CELC","MRNY","BMED","IBB","BBP","GDOC","FRTY","LABU","MEDI","PINK","SYNB","BK4139","RSPH","PSCH","MRNX","IDNA","LFSC","TECB","IYH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651337486","title":"3 Service Sector Stocks With Pricing Power Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2651337486","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651337486?lang=en_us&edition=fundamental","pubTime":"2026-07-15 02:47","pubTimestamp":1784054860,"startTime":"0","endTime":"0","summary":"Inflation is getting pulled in different directions right now, with energy swings, higher services costs, tech demand, and war driven spending all feeding into the same story. That mix can be uncomfortable for markets, but it can also create clear winners and losers as pricing power, cost control, and business models are put to the test. This article looks at 3 service sector stocks from our screener that appear closely tied to these trends and explains how the recent news could affect them...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-livn/livanova/news/3-service-sector-stocks-with-pricing-power-investors-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-livn/livanova/news/3-service-sector-stocks-with-pricing-power-investors-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","LU0130103400.USD","PW","LU1201861165.SGD","BK4084","IE0034390439.USD","LU0130518102.USD","LFSC","LU2065170008.USD","LU0477156797.USD","BK4234","ALHC","IE00B19Z6F94.USD","BK4539","BK4154","LU2065169927.USD","BK4082","LIVN","NVST","ISBC","LU2065171402.SGD","LU2065171311.SGD","LU0648000940.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105407","title":"Caris Life Sciences expands prostate cancer offering with PTEN IHC testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105407?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032510,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) will offer in-house PTEN immunohistochemistry, or IHC, testing following the recent FDA approval of a biomarker-guided th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4162","GDOC","MRNY","BK4104","MEDI","SYNB","BBP","CAI","IYH","IBB","BMED","BK4585","RSPH","TECB","BK4139","FRTY","PTEN","MRNX","PSCH","BK4092","IDNA","IHC","LFSC","BK4588","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651103511","title":"Guardant Health is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2651103511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651103511?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:05","pubTimestamp":1784030700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 14, 2026 08:05 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0109394709.USD","HELX","GH","BK4588","BK4535","GNOM","BK4551","LU0889565916.HKD","LU0320765992.SGD","LFSC","GDOC","EKG","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177472","title":"Guardant Health price target raised to $205 from $135 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177472?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:56","pubTimestamp":1784026600,"startTime":"0","endTime":"0","summary":"Canaccord analyst Kyle Mikson raised the firm’s price target on Guardant Health (GH) to $205 from $135 and keeps a Buy rating on the shares. The fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-205-from-135-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-205-from-135-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","EKG","BK4551","PTH","GH","LU0889565916.HKD","LU0109394709.USD","BK4585","BK4588","LU0320765992.SGD","BK4196","HELX","GNOM","BK4535","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651422771","title":"BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2651422771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651422771?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:08","pubTimestamp":1783980525,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an update. BioArctic’s partner Eisai has secured U.S. FDA approval for Leqembi Iqlik, a once-weekl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","PSCH","LU0532188223.SGD","SYNB","LU0516423174.USD","IE0031814969.USD","LU2065171402.SGD","LU1861220207.SGD","LU0251143029.SGD","IYH","LABU","MRNY","SG9999014484.SGD","LU0823039010.USD","SG9999002679.SGD","BK4220","HBCP","LU2360107671.USD","MEDI","RSPH","SG9999002414.USD","LU0499858438.USD","TECB","BK4585","IDNA","FDNI","BK4503","PINK","LU0589944569.HKD","BBP","BK4535","GDOC","LU0516423091.SGD","FRTY","LU0516422366.SGD","BK4554","MRNX","SG9999002406.SGD","SE","BMED","LU0441851309.USD","SG9999013478.USD","IBB","BK4588","SG9999014492.USD","LU2125910849.SGD","SG9999002620.SGD","LU2152927971.USD","LU2065170008.USD","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651145087","title":"Voyager Therapeutics advances tau-silencing gene therapy program","url":"https://stock-news.laohu8.com/highlight/detail?id=2651145087","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651145087?lang=en_us&edition=fundamental","pubTime":"2026-07-14 01:27","pubTimestamp":1783963636,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics ( ($VYGR) ) has provided an update. On July 13, 2026, Voyager Therapeutics presented three- and six-month good laboratory prac...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/voyager-therapeutics-advances-tau-silencing-gene-therapy-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/voyager-therapeutics-advances-tau-silencing-gene-therapy-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4139","LFSC","IBBQ","BK4585","FBT","VYGR","GNOM","BK4588","CNCR","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651129991","title":"Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651129991","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651129991?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:40","pubTimestamp":1783950037,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pediatrix Medical Group (MD) and Travere Therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pediatrix-medical-group-md-and-travere-therapeutics-tvtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pediatrix-medical-group-md-and-travere-therapeutics-tvtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","HCSG","LU0029874061.USD","BK4196","LU0128526141.USD","TVTX","BK4139","BK4588","LFSC","BK4585","FFTY","XLV","XBI","MD","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651436111","title":"Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436111","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651436111?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:00","pubTimestamp":1783944000,"startTime":"0","endTime":"0","summary":"Will create publicly traded advanced clean energy company focused on modular carbon-free energy, green hydrogen, critical materials and industrial decarbonization Business Combination expected to prov","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326126/32419/en/Matinas-BioPharma-Announces-Strategic-Business-Combination-with-GH-Power-to-Create-Publicly-Traded-Advanced-Clean-Energy-and-Green-Hydrogen-Company-Signs-Definitive-Agreement-to-Se.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4234","GDOC","HELX","EKG","GNOM","LNC","LU0109394709.USD","PTH","GSFP","PW","BK4596","LU0889565916.HKD","HYDR","BK4157","BK4535","BK4551","DBB","ICLN","AEIS","LU0320765992.SGD","CTEC","LFSC","BK4585","BK4084","IE00B19Z4B17.USD","IE0031619046.USD","LU1815336091.USD","GH","LU0757428866.USD","CCSO","IE00B66KJ199.SGD","BK4196","IE00B7SZL793.SGD","BK4588","BK4162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156997423","title":"Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS","url":"https://stock-news.laohu8.com/highlight/detail?id=1156997423","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156997423?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:10","pubTimestamp":1783908642,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) shares rose more than 7% in early trading. At the time of writing, the stock is up 6.21% to HK$45.48, with a turnover of HK$332 million. On July 13th, according to a post on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1593","LU2488822045.USD","BK1191","IE00BGHQDM52.EUR","IE00BYV24P56.USD","VTHR","BBP","SBIO","CHAT","00867","ARTY","SG9999015952.SGD","LFSC","GDOC","SG9999015945.SGD","WRND","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015978.USD","GSKH","AGIX","QTOC","BK4585","SG9999004220.SGD","IE00BMCWC346.EUR","AIPO","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137729","title":"Travere Therapeutics Grants Inducement Equity Awards for 41,600 Shares to Six New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137729","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137729?lang=en_us&edition=fundamental","pubTime":"2026-07-11 05:00","pubTimestamp":1783717216,"startTime":"0","endTime":"0","summary":"Travere Therapeutics grants inducement equity awards for 41,600 shares to six new employeesTravere Therapeutics granted inducement equity awards covering 41,600 shares to six new employees on July 10,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDLc2d4yj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","TVTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650045479","title":"Spyre Therapeutics (SYRE) Faces Broad Russell Index Removal Is Benchmark Appeal Quietly Eroding?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650045479","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650045479?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:23","pubTimestamp":1783650199,"startTime":"0","endTime":"0","summary":"In late June 2026, Spyre Therapeutics, Inc. (NasdaqGS: SYRE) was removed from several Russell indices, including the Russell 2000 Value, 2500 Value, 3000 Value, 3000E Value, and Small Cap Comp Value benchmarks.\nThis broad index exclusion matters because many passive and benchmark-aware investors adjust their holdings around such reconstitutions, potentially altering trading patterns and liquidity for the stock.\nNext, we will examine how this broad Russell index removal shapes Spyre...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-syre/spyre-therapeutics/news/spyre-therapeutics-syre-faces-broad-russell-index-removal-is","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-syre/spyre-therapeutics/news/spyre-therapeutics-syre-faces-broad-russell-index-removal-is","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SYRE","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650972432","title":"Travere Therapeutics CAO Sandra Calvin to Retire; Controller John Torell Set to Succeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2650972432","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650972432?lang=en_us&edition=fundamental","pubTime":"2026-07-10 05:11","pubTimestamp":1783631461,"startTime":"0","endTime":"0","summary":"Travere Therapeutics CAO Sandra Calvin to retire; controller John Torell set to succeedTravere Therapeutics disclosed that Chief Accounting Officer Sandra Calvin will retire following the filing of it","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL52XvQk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","TVTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":198,"code":"91000000","status":"200"}]}}